...
首页> 外文期刊>International Journal of Cancer =: Journal International du Cancer >Genetic dissection of the Mss4 locus mediating sex-biased cancer resistance in the rat peripheral nervous system
【24h】

Genetic dissection of the Mss4 locus mediating sex-biased cancer resistance in the rat peripheral nervous system

机译:Mss4基因座的遗传解剖介导大鼠周围神经系统中性别偏向的癌症抗性

获取原文
获取原文并翻译 | 示例

摘要

The incidence of neural tumors is sexually dimorphic in both, humans and rodents. The identification of genetic determinants contributing to sex-biased tumor development is an essential prerequisite for differential tumor prevention in males and females. F-2 hybrids of inbred BDIV and BDIX rats, resistant and susceptible, respectively, to ethylnitrosourea-induced malignant peripheral nerve sheath tumors (MPNST) display a marked sex bias regarding tumor risk. Homozygous BDIV alleles at the Mss4 locus (90.9-111.2 Mb, chromosome 6) mediate MPNST resistance exclusively in female F-2 rats according to a genome wide association analysis. This locus was functionally confirmed and fine mapped through MPNST induction in males and females of three congenic rat strains (BDIX.BDIV-Mss4a, b, d). As a consequence, it could be subdivided in Mss4.1 (98.8-99.7 Mb) mediating cancer resistance, and Mss4.2 (99.7-111.2 Mb) enhancing sex specificity. Positional candidate genes were selected through DNA sequencing and expression profiling using RNAs from trigeminal nerve tissue of parental and congenic male and female animals. The transregulatory fingerprint of BDIV or BDIX alleles at Mss4.1 and/or Mss4.2, respectively, provided insight into the processes influencing cancer risk in a sex-biased way. A group of genes, a fraction of which involved in Schwann cell differentiation, showed low, male-biased expression in nerve tissues under the control of BDIX susceptibility alleles, but high, female-biased transcript levels when controlled by BDIV resistance alleles at Mss4. The Esr2 gene located in Mss4.1 constitutes an interesting functional candidate together with a yet unidentified gene/enhancer in Mss4.2.
机译:在人类和啮齿动物中,神经肿瘤的发生在性别上都是两性的。鉴定导致性别偏向的肿瘤发展的遗传决定因素是男女差异性肿瘤预防的必要先决条件。分别对乙基亚硝基脲诱导的恶性周围神经鞘瘤(MPNST)有抗性和敏感性的近交BDIV和BDIX大鼠的F-2杂种表现出明显的性别偏见。根据全基因组关联分析,Mss4基因座的纯合子BDIV等位基因(90.9-111.2 Mb,染色体6)仅在雌性F-2大鼠中介导MPNST抗性。通过MPNST诱导在三个同系大鼠品系(BDIX.BDIV-Mss4a,b,d)的雄性和雌性中对该功能性基因座进行了功能确认和精细定位。因此,它可以细分为Mss4.1(98.8-99.7 Mb)介导抗癌性,而Mss4.2(99.7-111.2 Mb)可以增强性别特异性。通过DNA测序和表达谱分析,使用来自亲本和同基因雄性和雌性动物三叉神经组织的RNA选择位置候选基因。分别在Mss4.1和/或Mss4.2处进行的BDIV或BDIX等位基因的跨调节指纹图谱,为以性别偏见的方式影响癌症风险的过程提供了见识。一组基因(其中一部分参与雪旺氏细胞分化)在BDIX易感性等位基因的控制下在神经组织中表现出较低的男性偏向表达,但在Mss4受BDIV耐药性等位基因控制时,女性偏向于较高的转录水平。位于Mss4.1中的Esr2基因与Mss4.2中尚未鉴定的基因/增强子一起构成了一个有趣的功能候选物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号